Novartis Oncology Universal Co-pay Program: Rydapt

Funded
About
The Novartis Oncology Universal Co-pay Program: Rydapt provides substantial financial assistance to patients by significantly reducing out-of-pocket costs for the drug Rydapt. Through this program, commercially insured patients can reduce their expenses to a manageable $25 per month while Novartis covers up to $15,000 annually. This initiative ensures that access to Rydapt becomes more affordable for those covered by private insurance, enhancing treatment accessibility and adherence.
Insurance requirements: Commercially insured
As low as: $25 per mo
Enrollment Forms
Enrollment Form
Benefits
•$15000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•Commercially insured patients pay no more than $25 per month; program pays up to $15,000 per calendar year
•Card can be printed for immediate use following online eligibility questions and registration
•Offer may not be combined with any other rebate, coupon, or other offer(s)
•Patient automatically reenrolled on the 1st of each calendar year if commercial insurance remains active and covers drug (Novartis copay cards DO NOT EXPIRE)